EKF’s new facilities in Llandough, Cardiff, for the manufacture of PrimeStore® MTM viral transport media, enabling pathogenic samples to be collected and transported safely and easily in compliance ...

EKF Diagnostics Holdings' estimated fair value is UK£0.56 based on 2 Stage Free Cash Flow to Equity Current share price of UK£0.28 suggests EKF Diagnostics Holdings is potentially 49% undervalued The ...

EKF Diagnostics, the global in vitro diagnostics company, has appointed Luke Daum PhD as Chief Scientific Officer (CSO), bringing a wealth of expertise in molecular-based diagnostics to EKF’s ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

EKF Diagnostics Holdings (LON:EKF) has had a rough three months with its share price down 5.7%. We, however decided to study the company's financials to determine if they have got anything to do with ...

EKF Diagnostics, the global in vitro diagnostics company, announces the launch of its new EKF Link digital connectivity solution for the secure management of point-of-care (POC) analyzers and ...

Following this buyback, EKF’s total issued share capital consists of 449,093,790 ordinary shares, with 9,174,636 shares held in treasury, leaving 439,919,154 shares with voting rights. As part of the ...

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a leading global provider of engineered solutions and services for biotech manufacturing, today announced it will provide customized, large-scale bioprocess ...